(PharmaNewsWire.Com, October 01, 2020 ) The wound debridement market is projected to reach a value of USD 1,162 million by 2025 from USD 822 million in 2020, at a CAGR of 7.2% from 2020 to 2025. The high incidence of diabetes and other target diseases, the availability of reimbursement for wound debridement in developed economies, and the increasing number of burn cases are driving the growth of the wound debridement market.
The enzymatic debridement segment accounted for the largest share of the wound debridement market, by product, in 2019
Based on product, the wound debridement market is categorized into enzymatic, autolytic, mechanical, surgical, ultrasonic, and others. The enzymatic debridement products segment commanded the largest share of the global wound debridement market in 2019. This is primarily attributed to factors such as their high efficacy in debriding and strong market penetration.
Diabetic foot ulcers segment to register the highest growth rate during the forecast period
Based on wound type, the wound debridement market has been segmented into diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), pressure ulcers, surgical & traumatic wounds, burns, and other wounds. The DFUs segment is expected to grow at the highest rate during the forecast period. This is primarily due to the increasing prevalence of diabetes and the rising geriatric population.
North America is the largest regional market for wound debridement
The wound debridement market, by region, has been segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). North America is the largest market for wound debridement, followed by Europe. Growth in the North American market can be attributed to the increasing prevalence of diabetes, high penetration of enzymatic debridement products, and strong market player presence. However, the Asia Pacific market is expected to register the highest CAGR during the forecast period. Growth in this region is driven by the presence of a large patient population and increasing awareness regarding advanced healthcare products.
The prominent players operating in the wound debridement market include Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Coloplast (Denmark), ConvaTec (UK), Mölnlycke Healthcare (Sweden), Lohmann & Rauscher (Germany), Integra Lifesciences (US), Zimmer Biomet (US), Misonix (US), and Paul Hartmann AG (Germany).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
